Mural Josephson Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Josephson MGLN stock SEC Form 4 insiders trading

Mural has made over 6 trades of the Magellan Health Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 6,655 units of MGLN stock worth $153,797 on 5 March 2018.

The largest trade he's ever made was exercising 11,278 units of Magellan Health Inc stock on 1 December 2017 worth over $1,071,297. On average, Mural trades about 2,459 units every 23 days since 2016. As of 5 March 2018 he still owns at least 25,064 units of Magellan Health Inc stock.

You can see the complete history of Mr. Josephson stock trades at the bottom of the page.

Mural Josephson biography

Mural R. Josephson serves as Director of the Company. Mr. Josephson is a retired insurance executive who most recently was with Kemper Insurance Companies, having retired in 2002. At Kemper, he held key management positions, including senior vice president and chief financial officer, as well as senior vice president of finance. Prior to joining Kemper, Josephson held several senior level positions at KPMG, including 19 years as an audit partner. From 2007 until he retired in April 2020, he served on the board of directors of Argo Group International Holdings, Ltd., as a member of the audit committee. Josephson also recently served on the board of directors and as chair of the audit committee at HealthMarkets, Inc. Josephson is a registered certified public accountant in Illinois.

How old is Mural Josephson?

Mural Josephson is 70, he's been the Director of Magellan Health Inc since 2020. There are no older and 14 younger executives at Magellan Health Inc.

Insiders trading at Magellan Health Inc

Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray, and Mary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.

What does Magellan Health Inc do?

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Magellan Health Inc executives and stock owners

Magellan Health Inc executives and other stock owners filed with the SEC include:

• Kenneth Fasola,
  Chief Executive Officer, Director
• Mostafa Kamal,
  Chief Executive Officer - Magellan Rx Management
• Steven Shulman,
  Independent Chairman of the Board
• Caskie Lewis-Clapper,
  Chief Human Resource Officer
• Peter Feld,
  Independent Director
• G. Scott MacKenzie,
  Independent Director
• Guy Sansone,
  Independent Director
• Leslie Norwalk,
  Independent Director
• Swati Abbott,
  Independent Director
• Joe Bogdan,
  Senior Vice President, Corporate Finance
• Mural Josephson,
  Director
• Christopher Chen,
  Director
• Tim Lacy,
  Chief Growth Officer
• Caroline Carney,
  Chief Medical Officer
• David Haddock,
  General Counsel, Secretary
• David Bourdon,
  Chief Financial Officer
• James Murray,
  President, Chief Operating Officer
• Jay Youell,
  Sr. VP of Sales - Health Plan & Insurance Markets
• John E. Littel,
  Chief External Affairs Officer
• Darren P. Lehrich,
  Chief Investor Relations Officer
• Renie Shapiro Silver,
  SVP - Corp. Fin.
• David Patrick Bourdon,
  Chief Financial Officer
• William J Mcbride,
  Director
• Eran Broshy,
  Director
• Barry M Smith,
  Director
• Perry G Md Fine,
  Director
• Kay Coles James,
  Director
• John O Agwunobi,
  Director
• Jeffrey N West,
  SVP & Controller
• Sanjeev K Srivastava,
  CEO, Magellan Plan Services
• Mary F Sammons,
  Director
• Jonathan N Rubin,
  Chief Financial Officer
• Michael Diament,
  Director
• Daniel N Gregoire,
  General Counsel and Secretary
• Russell C Petrella,
  President, Behavioral Health
• Mark S Demilio,
  CFO
• Raju L Mantena,
  President, ICORE Healthcare
• Robert W Field,
  CEO, Magellan Pharm Solutions
• Michael P Ressner,
  Director
• Tina Blasi,
  CEO, National Imaging Assoc.
• Robert M Leblanc,
  Director
• Management, L.P.Cohen Arthu...,
  
• Kim Marie Mageau,
  President, Magellan Pharm Sols
• Alan Lotvin,
  President, ICore Healthcare
• Management, L.P.Health Cor ...,
  
• Timothy P Nolan,
  President, First Health Servic
• Karen S Lynch,
  President
• Nancy L Johnson,
  Director
• Allen F Wise,
  Director
• Jeff D Emerson,
  Chief Information Officer
• Rene Lerer,
  President and COO
• Eric Reimer,
  Chief Growth Officer
• William D Forrest,
  Director
• Anthony M Kotin,
  Chief Mkting & Strategy Offcr
• Saul Burian,
  Director
• Keith Dixon,
  President, Behavioral Health
• Holdings Lp Onex Partners G...,
  
• Michael Majerik,
  Chief Sales&Marketing Officer
• Matthew Joseph Simas,
  Director
• Robert M Haft,
  Director
• Gadget, L.P.Scepter Holding...,
  
• Megan M Arthur,
  Executive Vice President
• Holdings Lponex Partners Lp...,